Pharmaceutical industry executives urged the next FDA commissioner to restore regulatory predictability following Commissioner Marty Makary's resignation, according to Axios. Said PhRMA CEO Steve Ubl: "What we really need from the next leader of the FDA is to calm the waters and reestablish that certainty and predictability." Bristol Myers Squibb CEO Chris Boerner echoed the call, citing the years of investment required to bring a drug to market.